These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 3690354)

  • 1. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
    Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acetylcholine binding sites in Alzheimer's disease.
    Whitehouse PJ; Martino AM; Antuono PG; Lowenstein PR; Coyle JT; Price DL; Kellar KJ
    Brain Res; 1986 Apr; 371(1):146-51. PubMed ID: 3708340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
    Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine.
    Tilson HA; Schwartz RD; Ali SF; McLamb RL
    Neuropharmacology; 1989 Aug; 28(8):855-61. PubMed ID: 2779754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics.
    Hellström-Lindahl E; Winblad B; Nordberg A
    Brain Res; 1993 Aug; 620(1):42-8. PubMed ID: 8402197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.
    Nordberg A; Winblad B
    Neurosci Lett; 1986 Dec; 72(1):115-9. PubMed ID: 3808458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain.
    Aubert I; Cécyre D; Gauthier S; Quirion R
    J Comp Neurol; 1996 May; 369(1):31-55. PubMed ID: 8723701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
    Perry EK; Smith CJ; Court JA; Perry RH
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.
    Mash DC; Flynn DD; Potter LT
    Science; 1985 May; 228(4703):1115-7. PubMed ID: 3992249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic distribution of high affinity muscarinic and nicotinic cholinergic receptors labeled with [3H]acetylcholine in rat brain.
    Schwartz RD
    Life Sci; 1986 Jun; 38(23):2111-9. PubMed ID: 3713440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
    Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
    J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes.
    Svensson AL; Warpman U; Hellström-Lindahl E; Bogdanovic N; Lannfelt L; Nordberg A
    Neurosci Lett; 1997 Aug; 232(1):37-40. PubMed ID: 9292886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductions in acetylcholine and nicotine binding in several degenerative diseases.
    Whitehouse PJ; Martino AM; Marcus KA; Zweig RM; Singer HS; Price DL; Kellar KJ
    Arch Neurol; 1988 Jul; 45(7):722-4. PubMed ID: 3390025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.
    Flynn DD; Mash DC
    J Neurochem; 1986 Dec; 47(6):1948-54. PubMed ID: 3772387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.
    Whitehouse PJ; Martino AM; Wagster MV; Price DL; Mayeux R; Atack JR; Kellar KJ
    Neurology; 1988 May; 38(5):720-3. PubMed ID: 3362368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
    Sihver W; Gillberg PG; Svensson AL; Nordberg A
    Neuroscience; 1999; 94(3):685-96. PubMed ID: 10579560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
    Shiozaki K; Iseki E; Uchiyama H; Watanabe Y; Haga T; Kameyama K; Ikeda T; Yamamoto T; Kosaka K
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):209-13. PubMed ID: 10406992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.